aluates Reports

$ 0.0

Automative

Global Prescription Medicine Market Research Report 2024

Published Date: March 2024

Report Code: QYRE-Auto-31K9957

Global Prescription Medicine Market Insights Forecast to 2028

BUY CHAPTERS

Global Prescription Medicine Market Research Report 2024

Code: QYRE-Auto-31K9957

Report

March 2024

Pages:100

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Prescription Medicine Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Prescription Medicine Market

The global Prescription Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Prescription Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prescription Medicine.

Report Scope

The Prescription Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prescription Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Prescription Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Prescription Medicine Market Report

Report Metric	Details
Report Name	Prescription Medicine Market
CAGR	5%
Segment by Type	Original Brand Drug Generic Drug
Segment by Application	Hospital Clinic Online Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Roche, Novartis, Johnson & Johnson, Merck & Co., Sanofi, AbbVie, GlaxoSmithKline, Amgen, Gilead Science, Bristol-Myers Squibb, AstraZeneca, Eli Lilly, Bayer, Novo Nordisk, Takeda, Boehringer-Ingelheim, Allergan, Teva Pharmaceutical Industries, Mylan, Astellas Pharma, Biogen, CSL, Daiichi Sankyo, Otsuka Holdings, UCB, LES LABORATOIRES SERVIER, Bausch Health Companies, Eisai, Abbott Laboratories
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prescription Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Prescription Medicine Market report?

Ans: The main players in the Prescription Medicine Market are Pfizer, Roche, Novartis, Johnson & Johnson, Merck & Co., Sanofi, AbbVie, GlaxoSmithKline, Amgen, Gilead Science, Bristol-Myers Squibb, AstraZeneca, Eli Lilly, Bayer, Novo Nordisk, Takeda, Boehringer-Ingelheim, Allergan, Teva Pharmaceutical Industries, Mylan, Astellas Pharma, Biogen, CSL, Daiichi Sankyo, Otsuka Holdings, UCB, LES LABORATOIRES SERVIER, Bausch Health Companies, Eisai, Abbott Laboratories

What are the Application segmentation covered in the Prescription Medicine Market report?

Ans: The Applications covered in the Prescription Medicine Market report are Hospital, Clinic, Online, Others

What are the Type segmentation covered in the Prescription Medicine Market report?

Ans: The Types covered in the Prescription Medicine Market report are Original Brand Drug, Generic Drug

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Prescription Medicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Original Brand Drug

1.2.3 Generic Drug

1.3 Market by Application

1.3.1 Global Prescription Medicine Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Online

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Prescription Medicine Market Perspective (2019-2030)

2.2 Prescription Medicine Growth Trends by Region

2.2.1 Global Prescription Medicine Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Prescription Medicine Historic Market Size by Region (2019-2024)

2.2.3 Prescription Medicine Forecasted Market Size by Region (2025-2030)

2.3 Prescription Medicine Market Dynamics

2.3.1 Prescription Medicine Industry Trends

2.3.2 Prescription Medicine Market Drivers

2.3.3 Prescription Medicine Market Challenges

2.3.4 Prescription Medicine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Prescription Medicine Players by Revenue

3.1.1 Global Top Prescription Medicine Players by Revenue (2019-2024)

3.1.2 Global Prescription Medicine Revenue Market Share by Players (2019-2024)

3.2 Global Prescription Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Prescription Medicine Revenue

3.4 Global Prescription Medicine Market Concentration Ratio

3.4.1 Global Prescription Medicine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Prescription Medicine Revenue in 2023

3.5 Prescription Medicine Key Players Head office and Area Served

3.6 Key Players Prescription Medicine Product Solution and Service

3.7 Date of Enter into Prescription Medicine Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Prescription Medicine Breakdown Data by Type

4.1 Global Prescription Medicine Historic Market Size by Type (2019-2024)

4.2 Global Prescription Medicine Forecasted Market Size by Type (2025-2030)

5 Prescription Medicine Breakdown Data by Application

5.1 Global Prescription Medicine Historic Market Size by Application (2019-2024)

5.2 Global Prescription Medicine Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Prescription Medicine Market Size (2019-2030)

6.2 North America Prescription Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Prescription Medicine Market Size by Country (2019-2024)

6.4 North America Prescription Medicine Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Prescription Medicine Market Size (2019-2030)

7.2 Europe Prescription Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Prescription Medicine Market Size by Country (2019-2024)

7.4 Europe Prescription Medicine Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Prescription Medicine Market Size (2019-2030)

8.2 Asia-Pacific Prescription Medicine Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Prescription Medicine Market Size by Region (2019-2024)

8.4 Asia-Pacific Prescription Medicine Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Prescription Medicine Market Size (2019-2030)

9.2 Latin America Prescription Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Prescription Medicine Market Size by Country (2019-2024)

9.4 Latin America Prescription Medicine Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Prescription Medicine Market Size (2019-2030)

10.2 Middle East & Africa Prescription Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Prescription Medicine Market Size by Country (2019-2024)

10.4 Middle East & Africa Prescription Medicine Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Prescription Medicine Introduction

11.1.4 Pfizer Revenue in Prescription Medicine Business (2019-2024)

11.1.5 Pfizer Recent Development

11.2 Roche

11.2.1 Roche Company Detail

11.2.2 Roche Business Overview

11.2.3 Roche Prescription Medicine Introduction

11.2.4 Roche Revenue in Prescription Medicine Business (2019-2024)

11.2.5 Roche Recent Development

11.3 Novartis

11.3.1 Novartis Company Detail

11.3.2 Novartis Business Overview

11.3.3 Novartis Prescription Medicine Introduction

11.3.4 Novartis Revenue in Prescription Medicine Business (2019-2024)

11.3.5 Novartis Recent Development

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Detail

11.4.2 Johnson & Johnson Business Overview

11.4.3 Johnson & Johnson Prescription Medicine Introduction

11.4.4 Johnson & Johnson Revenue in Prescription Medicine Business (2019-2024)

11.4.5 Johnson & Johnson Recent Development

11.5 Merck & Co.

11.5.1 Merck & Co. Company Detail

11.5.2 Merck & Co. Business Overview

11.5.3 Merck & Co. Prescription Medicine Introduction

11.5.4 Merck & Co. Revenue in Prescription Medicine Business (2019-2024)

11.5.5 Merck & Co. Recent Development

11.6 Sanofi

11.6.1 Sanofi Company Detail

11.6.2 Sanofi Business Overview

11.6.3 Sanofi Prescription Medicine Introduction

11.6.4 Sanofi Revenue in Prescription Medicine Business (2019-2024)

11.6.5 Sanofi Recent Development

11.7 AbbVie

11.7.1 AbbVie Company Detail

11.7.2 AbbVie Business Overview

11.7.3 AbbVie Prescription Medicine Introduction

11.7.4 AbbVie Revenue in Prescription Medicine Business (2019-2024)

11.7.5 AbbVie Recent Development

11.8 GlaxoSmithKline

11.8.1 GlaxoSmithKline Company Detail

11.8.2 GlaxoSmithKline Business Overview

11.8.3 GlaxoSmithKline Prescription Medicine Introduction

11.8.4 GlaxoSmithKline Revenue in Prescription Medicine Business (2019-2024)

11.8.5 GlaxoSmithKline Recent Development

11.9 Amgen

11.9.1 Amgen Company Detail

11.9.2 Amgen Business Overview

11.9.3 Amgen Prescription Medicine Introduction

11.9.4 Amgen Revenue in Prescription Medicine Business (2019-2024)

11.9.5 Amgen Recent Development

11.10 Gilead Science

11.10.1 Gilead Science Company Detail

11.10.2 Gilead Science Business Overview

11.10.3 Gilead Science Prescription Medicine Introduction

11.10.4 Gilead Science Revenue in Prescription Medicine Business (2019-2024)

11.10.5 Gilead Science Recent Development

11.11 Bristol-Myers Squibb

11.11.1 Bristol-Myers Squibb Company Detail

11.11.2 Bristol-Myers Squibb Business Overview

11.11.3 Bristol-Myers Squibb Prescription Medicine Introduction

11.11.4 Bristol-Myers Squibb Revenue in Prescription Medicine Business (2019-2024)

11.11.5 Bristol-Myers Squibb Recent Development

11.12 AstraZeneca

11.12.1 AstraZeneca Company Detail

11.12.2 AstraZeneca Business Overview

11.12.3 AstraZeneca Prescription Medicine Introduction

11.12.4 AstraZeneca Revenue in Prescription Medicine Business (2019-2024)

11.12.5 AstraZeneca Recent Development

11.13 Eli Lilly

11.13.1 Eli Lilly Company Detail

11.13.2 Eli Lilly Business Overview

11.13.3 Eli Lilly Prescription Medicine Introduction

11.13.4 Eli Lilly Revenue in Prescription Medicine Business (2019-2024)

11.13.5 Eli Lilly Recent Development

11.14 Bayer

11.14.1 Bayer Company Detail

11.14.2 Bayer Business Overview

11.14.3 Bayer Prescription Medicine Introduction

11.14.4 Bayer Revenue in Prescription Medicine Business (2019-2024)

11.14.5 Bayer Recent Development

11.15 Novo Nordisk

11.15.1 Novo Nordisk Company Detail

11.15.2 Novo Nordisk Business Overview

11.15.3 Novo Nordisk Prescription Medicine Introduction

11.15.4 Novo Nordisk Revenue in Prescription Medicine Business (2019-2024)

11.15.5 Novo Nordisk Recent Development

11.16 Takeda

11.16.1 Takeda Company Detail

11.16.2 Takeda Business Overview

11.16.3 Takeda Prescription Medicine Introduction

11.16.4 Takeda Revenue in Prescription Medicine Business (2019-2024)

11.16.5 Takeda Recent Development

11.17 Boehringer-Ingelheim

11.17.1 Boehringer-Ingelheim Company Detail

11.17.2 Boehringer-Ingelheim Business Overview

11.17.3 Boehringer-Ingelheim Prescription Medicine Introduction

11.17.4 Boehringer-Ingelheim Revenue in Prescription Medicine Business (2019-2024)

11.17.5 Boehringer-Ingelheim Recent Development

11.18 Allergan

11.18.1 Allergan Company Detail

11.18.2 Allergan Business Overview

11.18.3 Allergan Prescription Medicine Introduction

11.18.4 Allergan Revenue in Prescription Medicine Business (2019-2024)

11.18.5 Allergan Recent Development

11.19 Teva Pharmaceutical Industries

11.19.1 Teva Pharmaceutical Industries Company Detail

11.19.2 Teva Pharmaceutical Industries Business Overview

11.19.3 Teva Pharmaceutical Industries Prescription Medicine Introduction

11.19.4 Teva Pharmaceutical Industries Revenue in Prescription Medicine Business (2019-2024)

11.19.5 Teva Pharmaceutical Industries Recent Development

11.20 Mylan

11.20.1 Mylan Company Detail

11.20.2 Mylan Business Overview

11.20.3 Mylan Prescription Medicine Introduction

11.20.4 Mylan Revenue in Prescription Medicine Business (2019-2024)

11.20.5 Mylan Recent Development

11.21 Astellas Pharma

11.21.1 Astellas Pharma Company Detail

11.21.2 Astellas Pharma Business Overview

11.21.3 Astellas Pharma Prescription Medicine Introduction

11.21.4 Astellas Pharma Revenue in Prescription Medicine Business (2019-2024)

11.21.5 Astellas Pharma Recent Development

11.22 Biogen

11.22.1 Biogen Company Detail

11.22.2 Biogen Business Overview

11.22.3 Biogen Prescription Medicine Introduction

11.22.4 Biogen Revenue in Prescription Medicine Business (2019-2024)

11.22.5 Biogen Recent Development

11.23 CSL

11.23.1 CSL Company Detail

11.23.2 CSL Business Overview

11.23.3 CSL Prescription Medicine Introduction

11.23.4 CSL Revenue in Prescription Medicine Business (2019-2024)

11.23.5 CSL Recent Development

11.24 Daiichi Sankyo

11.24.1 Daiichi Sankyo Company Detail

11.24.2 Daiichi Sankyo Business Overview

11.24.3 Daiichi Sankyo Prescription Medicine Introduction

11.24.4 Daiichi Sankyo Revenue in Prescription Medicine Business (2019-2024)

11.24.5 Daiichi Sankyo Recent Development

11.25 Otsuka Holdings

11.25.1 Otsuka Holdings Company Detail

11.25.2 Otsuka Holdings Business Overview

11.25.3 Otsuka Holdings Prescription Medicine Introduction

11.25.4 Otsuka Holdings Revenue in Prescription Medicine Business (2019-2024)

11.25.5 Otsuka Holdings Recent Development

11.26 UCB

11.26.1 UCB Company Detail

11.26.2 UCB Business Overview

11.26.3 UCB Prescription Medicine Introduction

11.26.4 UCB Revenue in Prescription Medicine Business (2019-2024)

11.26.5 UCB Recent Development

11.27 LES LABORATOIRES SERVIER

11.27.1 LES LABORATOIRES SERVIER Company Detail

11.27.2 LES LABORATOIRES SERVIER Business Overview

11.27.3 LES LABORATOIRES SERVIER Prescription Medicine Introduction

11.27.4 LES LABORATOIRES SERVIER Revenue in Prescription Medicine Business (2019-2024)

11.27.5 LES LABORATOIRES SERVIER Recent Development

11.28 Bausch Health Companies

11.28.1 Bausch Health Companies Company Detail

11.28.2 Bausch Health Companies Business Overview

11.28.3 Bausch Health Companies Prescription Medicine Introduction

11.28.4 Bausch Health Companies Revenue in Prescription Medicine Business (2019-2024)

11.28.5 Bausch Health Companies Recent Development

11.29 Eisai

11.29.1 Eisai Company Detail

11.29.2 Eisai Business Overview

11.29.3 Eisai Prescription Medicine Introduction

11.29.4 Eisai Revenue in Prescription Medicine Business (2019-2024)

11.29.5 Eisai Recent Development

11.30 Abbott Laboratories

11.30.1 Abbott Laboratories Company Detail

11.30.2 Abbott Laboratories Business Overview

11.30.3 Abbott Laboratories Prescription Medicine Introduction

11.30.4 Abbott Laboratories Revenue in Prescription Medicine Business (2019-2024)

11.30.5 Abbott Laboratories Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global Prescription Medicine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Original Brand Drug

Table 3. Key Players of Generic Drug

Table 4. Global Prescription Medicine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Prescription Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Prescription Medicine Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Prescription Medicine Market Share by Region (2019-2024)

Table 8. Global Prescription Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Prescription Medicine Market Share by Region (2025-2030)

Table 10. Prescription Medicine Market Trends

Table 11. Prescription Medicine Market Drivers

Table 12. Prescription Medicine Market Challenges

Table 13. Prescription Medicine Market Restraints

Table 14. Global Prescription Medicine Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Prescription Medicine Market Share by Players (2019-2024)

Table 16. Global Top Prescription Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Medicine as of 2023)

Table 17. Ranking of Global Top Prescription Medicine Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Prescription Medicine Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Prescription Medicine Product Solution and Service

Table 21. Date of Enter into Prescription Medicine Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Prescription Medicine Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Prescription Medicine Revenue Market Share by Type (2019-2024)

Table 25. Global Prescription Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Prescription Medicine Revenue Market Share by Type (2025-2030)

Table 27. Global Prescription Medicine Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Prescription Medicine Revenue Market Share by Application (2019-2024)

Table 29. Global Prescription Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Prescription Medicine Revenue Market Share by Application (2025-2030)

Table 31. North America Prescription Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Prescription Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Prescription Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Prescription Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Prescription Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Prescription Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Prescription Medicine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Prescription Medicine Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Prescription Medicine Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Prescription Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Prescription Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Prescription Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Prescription Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Prescription Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Prescription Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 46. Pfizer Company Detail

Table 47. Pfizer Business Overview

Table 48. Pfizer Prescription Medicine Product

Table 49. Pfizer Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 50. Pfizer Recent Development

Table 51. Roche Company Detail

Table 52. Roche Business Overview

Table 53. Roche Prescription Medicine Product

Table 54. Roche Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 55. Roche Recent Development

Table 56. Novartis Company Detail

Table 57. Novartis Business Overview

Table 58. Novartis Prescription Medicine Product

Table 59. Novartis Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 60. Novartis Recent Development

Table 61. Johnson & Johnson Company Detail

Table 62. Johnson & Johnson Business Overview

Table 63. Johnson & Johnson Prescription Medicine Product

Table 64. Johnson & Johnson Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 65. Johnson & Johnson Recent Development

Table 66. Merck & Co. Company Detail

Table 67. Merck & Co. Business Overview

Table 68. Merck & Co. Prescription Medicine Product

Table 69. Merck & Co. Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 70. Merck & Co. Recent Development

Table 71. Sanofi Company Detail

Table 72. Sanofi Business Overview

Table 73. Sanofi Prescription Medicine Product

Table 74. Sanofi Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 75. Sanofi Recent Development

Table 76. AbbVie Company Detail

Table 77. AbbVie Business Overview

Table 78. AbbVie Prescription Medicine Product

Table 79. AbbVie Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 80. AbbVie Recent Development

Table 81. GlaxoSmithKline Company Detail

Table 82. GlaxoSmithKline Business Overview

Table 83. GlaxoSmithKline Prescription Medicine Product

Table 84. GlaxoSmithKline Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 85. GlaxoSmithKline Recent Development

Table 86. Amgen Company Detail

Table 87. Amgen Business Overview

Table 88. Amgen Prescription Medicine Product

Table 89. Amgen Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 90. Amgen Recent Development

Table 91. Gilead Science Company Detail

Table 92. Gilead Science Business Overview

Table 93. Gilead Science Prescription Medicine Product

Table 94. Gilead Science Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 95. Gilead Science Recent Development

Table 96. Bristol-Myers Squibb Company Detail

Table 97. Bristol-Myers Squibb Business Overview

Table 98. Bristol-Myers Squibb Prescription Medicine Product

Table 99. Bristol-Myers Squibb Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 100. Bristol-Myers Squibb Recent Development

Table 101. AstraZeneca Company Detail

Table 102. AstraZeneca Business Overview

Table 103. AstraZeneca Prescription Medicine Product

Table 104. AstraZeneca Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 105. AstraZeneca Recent Development

Table 106. Eli Lilly Company Detail

Table 107. Eli Lilly Business Overview

Table 108. Eli Lilly Prescription Medicine Product

Table 109. Eli Lilly Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 110. Eli Lilly Recent Development

Table 111. Bayer Company Detail

Table 112. Bayer Business Overview

Table 113. Bayer Prescription Medicine Product

Table 114. Bayer Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 115. Bayer Recent Development

Table 116. Novo Nordisk Company Detail

Table 117. Novo Nordisk Business Overview

Table 118. Novo Nordisk Prescription Medicine Product

Table 119. Novo Nordisk Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 120. Novo Nordisk Recent Development

Table 121. Takeda Company Detail

Table 122. Takeda Business Overview

Table 123. Takeda Prescription Medicine Product

Table 124. Takeda Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 125. Takeda Recent Development

Table 126. Boehringer-Ingelheim Company Detail

Table 127. Boehringer-Ingelheim Business Overview

Table 128. Boehringer-Ingelheim Prescription Medicine Product

Table 129. Boehringer-Ingelheim Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 130. Boehringer-Ingelheim Recent Development

Table 131. Allergan Company Detail

Table 132. Allergan Business Overview

Table 133. Allergan Prescription Medicine Product

Table 134. Allergan Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 135. Allergan Recent Development

Table 136. Teva Pharmaceutical Industries Company Detail

Table 137. Teva Pharmaceutical Industries Business Overview

Table 138. Teva Pharmaceutical Industries Prescription Medicine Product

Table 139. Teva Pharmaceutical Industries Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 140. Teva Pharmaceutical Industries Recent Development

Table 141. Mylan Company Detail

Table 142. Mylan Business Overview

Table 143. Mylan Prescription Medicine Product

Table 144. Mylan Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 145. Mylan Recent Development

Table 146. Astellas Pharma Company Detail

Table 147. Astellas Pharma Business Overview

Table 148. Astellas Pharma Prescription Medicine Product

Table 149. Astellas Pharma Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 150. Astellas Pharma Recent Development

Table 151. Biogen Company Detail

Table 152. Biogen Business Overview

Table 153. Biogen Prescription Medicine Product

Table 154. Biogen Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 155. Biogen Recent Development

Table 156. CSL Company Detail

Table 157. CSL Business Overview

Table 158. CSL Prescription Medicine Product

Table 159. CSL Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 160. CSL Recent Development

Table 161. Daiichi Sankyo Company Detail

Table 162. Daiichi Sankyo Business Overview

Table 163. Daiichi Sankyo Prescription Medicine Product

Table 164. Daiichi Sankyo Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 165. Daiichi Sankyo Recent Development

Table 166. Otsuka Holdings Company Detail

Table 167. Otsuka Holdings Business Overview

Table 168. Otsuka Holdings Prescription Medicine Product

Table 169. Otsuka Holdings Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 170. Otsuka Holdings Recent Development

Table 171. UCB Company Detail

Table 172. UCB Business Overview

Table 173. UCB Prescription Medicine Product

Table 174. UCB Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 175. UCB Recent Development

Table 176. LES LABORATOIRES SERVIER Company Detail

Table 177. LES LABORATOIRES SERVIER Business Overview

Table 178. LES LABORATOIRES SERVIER Prescription Medicine Product

Table 179. LES LABORATOIRES SERVIER Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 180. LES LABORATOIRES SERVIER Recent Development

Table 181. Bausch Health Companies Company Detail

Table 182. Bausch Health Companies Business Overview

Table 183. Bausch Health Companies Prescription Medicine Product

Table 184. Bausch Health Companies Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 185. Bausch Health Companies Recent Development

Table 186. Eisai Company Detail

Table 187. Eisai Business Overview

Table 188. Eisai Prescription Medicine Product

Table 189. Eisai Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 190. Eisai Recent Development

Table 191. Abbott Laboratories Company Detail

Table 192. Abbott Laboratories Business Overview

Table 193. Abbott Laboratories Prescription Medicine Product

Table 194. Abbott Laboratories Revenue in Prescription Medicine Business (2019-2024) & (US$ Million)

Table 195. Abbott Laboratories Recent Development

Table 196. Research Programs/Design for This Report

Table 197. Key Data Information from Secondary Sources

Table 198. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Prescription Medicine Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Prescription Medicine Market Share by Type: 2023 VS 2030

Figure 3. Original Brand Drug Features

Figure 4. Generic Drug Features

Figure 5. Global Prescription Medicine Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Prescription Medicine Market Share by Application: 2023 VS 2030

Figure 7. Hospital Case Studies

Figure 8. Clinic Case Studies

Figure 9. Online Case Studies

Figure 10. Others Case Studies

Figure 11. Prescription Medicine Report Years Considered

Figure 12. Global Prescription Medicine Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Prescription Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Prescription Medicine Market Share by Region: 2023 VS 2030

Figure 15. Global Prescription Medicine Market Share by Players in 2023

Figure 16. Global Top Prescription Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Medicine as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Prescription Medicine Revenue in 2023

Figure 18. North America Prescription Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Prescription Medicine Market Share by Country (2019-2030)

Figure 20. United States Prescription Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Prescription Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Prescription Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Prescription Medicine Market Share by Country (2019-2030)

Figure 24. Germany Prescription Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Prescription Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Prescription Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Prescription Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Prescription Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Prescription Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Prescription Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Prescription Medicine Market Share by Region (2019-2030)

Figure 32. China Prescription Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Prescription Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Prescription Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Prescription Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Prescription Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Prescription Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Prescription Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Prescription Medicine Market Share by Country (2019-2030)

Figure 40. Mexico Prescription Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Prescription Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Prescription Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Prescription Medicine Market Share by Country (2019-2030)

Figure 44. Turkey Prescription Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Prescription Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Pfizer Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 47. Roche Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 48. Novartis Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 49. Johnson & Johnson Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 50. Merck & Co. Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 51. Sanofi Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 52. AbbVie Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 53. GlaxoSmithKline Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 54. Amgen Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 55. Gilead Science Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 57. AstraZeneca Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 58. Eli Lilly Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 59. Bayer Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 60. Novo Nordisk Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 61. Takeda Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 62. Boehringer-Ingelheim Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 63. Allergan Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 64. Teva Pharmaceutical Industries Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 65. Mylan Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 66. Astellas Pharma Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 67. Biogen Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 68. CSL Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 69. Daiichi Sankyo Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 70. Otsuka Holdings Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 71. UCB Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 72. LES LABORATOIRES SERVIER Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 73. Bausch Health Companies Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 74. Eisai Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 75. Abbott Laboratories Revenue Growth Rate in Prescription Medicine Business (2019-2024)

Figure 76. Bottom-up and Top-down Approaches for This Report

Figure 77. Data Triangulation

Figure 78. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-31X2542

Thu Oct 10 00:00:00 UTC 2024

Add to Cart

ELISA Technologies - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-6C4296

Thu Oct 10 00:00:00 UTC 2024

Add to Cart

Blow-Fill-Seal (BFS) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-22N3952

Thu Oct 10 00:00:00 UTC 2024

Add to Cart

Membrane Technology in Pharma, Biopharma, And Life Science - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-5A6999

Thu Oct 10 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Prescription Medicine Market Research Report 2024

Published Date: March 2024

Report Code: QYRE-Auto-31K9957

Global Prescription Medicine Market Research Report 2024

FEATURED COMPANIES

Prescription Medicine Market Size

Prescription Medicine Market

Report Scope

Scope of Prescription Medicine Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Prescription Medicine Market report?

What are the Application segmentation covered in the Prescription Medicine Market report?

What are the Type segmentation covered in the Prescription Medicine Market report?

FEATURED COMPANIES

RELATED REPORTS